NCT05680792View on ClinicalTrials.gov

Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

January 10, 2023

Study Completion Date

January 31, 2023

Conditions
Drug Interaction
Interventions
DRUG

Nitazoxanide

1000 mg nitazoxanide tablets twice daily. The drug will be administered after meal for 5 days

DRUG

Atazanavir/ritonavir

300/100 mg atazanavir/ritonavir tablets in the evening once daily, to be administered after meal for 5 days.

Trial Locations (1)

220101

Obafemi Awolowo University, Ile-Ife

All Listed Sponsors
collaborator

University of Liverpool

OTHER

lead

Obafemi Awolowo University

OTHER

NCT05680792 - Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers | Biotech Hunter | Biotech Hunter